Disease Modification in Urticaria

In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka from Hiroshima University, Japan, about an important question many patients ask: how long will chronic urticaria last, and can treatment influence the course of the disease? They discuss disease modification, symptom control, and future research directions in urticaria management.

They discuss:

🔹 How long does chronic spontaneous urticaria typically last?

🔹 Can early and effective treatment shorten disease duration?

🔹 Why is complete symptom control an important treatment goal?

🔹 What role do antihistamines, omalizumab, dupilumab, and remibrutinib play in long-term management?

🔹 Could food-related pseudoallergic reactions contribute to persistent symptoms?

🔹 What might the gut microbiome teach us about urticaria in the future?

🔹 How can international collaboration help answer these unanswered questions?

The discussion explores the possibility that optimal disease control may do more than relieve symptoms—it may also influence the overall course of urticaria. The episode highlights emerging ideas around disease modification, dietary influences, and the microbiome, while emphasizing the need for future research.

Key Learnings from the Episode:

Chronic spontaneous urticaria is usually a temporary disease, not a lifelong condition.

Many patients achieve remission, although it may take several years.

Complete symptom control should be a key treatment goal.

Early and effective treatment may potentially shorten disease duration.

Antihistamines remain an important foundation of treatment.

Add-on therapies such as omalizumab, dupilumab, and remibrutinib expand treatment options.

Food-related pseudoallergic reactions may contribute to symptoms in some patients.

The gut microbiome may play a role in urticaria and warrants further research.

Patient education and reassurance are important parts of care.

International research networks such as UCARE help advance knowledge and improve outcomes.

Chapters

00:00 Introduction of Experts and Topic Overview

01:04 Patient Questions About Disease Duration

02:08 Statistics on Long-Term Urticaria and Hopeful Messaging

04:23 Disease Modification and Early Treatment Strategies

06:24 Impact of Symptom Control on Disease Duration

08:29 Guidelines for Treatment Escalation and New Therapies

10:01 Combination Therapy and Disease Management Goals

12:07 Role of Food, Pseudoallergy, and Microbiome in Urticaria

14:18 Research on Microbiome and Traditional Diets

16:29 Closing Remarks and Future Directions

Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

Feedback form: ATU: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH